SG Americas Securities, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$383
-51.4%
18,607
+11.0%
0.00%
-33.3%
Q2 2023$788
+69.5%
16,760
+51.1%
0.01%
+20.0%
Q1 2023$465
-46.9%
11,092
-51.7%
0.01%
-54.5%
Q4 2022$876
-99.8%
22,974
+119.0%
0.01%
+120.0%
Q3 2022$411,000
-48.0%
10,492
-57.1%
0.01%
-37.5%
Q2 2022$791,000
-76.2%
24,481
-75.6%
0.01%
-66.7%
Q1 2022$3,327,000
+440.1%
100,509
+594.2%
0.02%
+700.0%
Q4 2021$616,000
-79.5%
14,478
-78.6%
0.00%
-78.6%
Q3 2021$3,002,000
+118.8%
67,750
+180.5%
0.01%
+133.3%
Q2 2021$1,372,000
-7.7%
24,151
+21.5%
0.01%
-25.0%
Q1 2021$1,487,000
-20.1%
19,870
-7.7%
0.01%
-20.0%
Q4 2020$1,862,000
+74.8%
21,519
+23.5%
0.01%
+42.9%
Q3 2020$1,065,000
+103.2%
17,431
+366.4%
0.01%
+75.0%
Q3 2019$524,000
+35.4%
3,737
+77.0%
0.00%
+33.3%
Q2 2019$387,000
+15.5%
2,111
+0.3%
0.00%0.0%
Q1 2019$335,000
+3.4%
2,104
-37.8%
0.00%0.0%
Q4 2018$324,000
-11.0%
3,385
+31.5%
0.00%0.0%
Q3 2018$364,000
+160.0%
2,575
+187.7%
0.00%
+200.0%
Q2 2018$140,000
-83.4%
895
-82.9%
0.00%
-85.7%
Q1 2018$843,000
+98.4%
5,233
-23.2%
0.01%
+75.0%
Q3 2017$425,000
+58.6%
6,814
+102.9%
0.00%
+100.0%
Q2 2017$268,000
+7.2%
3,359
-4.7%
0.00%0.0%
Q1 2017$250,000
-65.2%
3,524
-75.0%
0.00%
-66.7%
Q4 2016$719,000
+192.3%
14,078
+163.5%
0.01%
+100.0%
Q3 2016$246,000
+70.8%
5,343
+56.7%
0.00%
+200.0%
Q3 2015$144,000
-8.9%
3,409
-20.8%
0.00%0.0%
Q4 2014$158,0004,3050.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders